Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum

Rhea-AI Summary

Parnell Pharmaceuticals Holdings Ltd announces its Annual General Meeting to be held on December 1st, 2023. The meeting will take place at the company's headquarters in Australia. Shareholders will have the opportunity to review the financial statements, ratify the appointment of the company auditor, and re-elect Mr. Doug Schillinger as a director.

SYDNEY, AUSTRALIA / ACCESSWIRE / November 6, 2023 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, provides notice of its Annual General Meeting to be held Friday, December 1st 2023 at 8:30 a.m. (Australian Eastern Standard Time).

NOTICE OF ANNUAL GENERAL MEETING AND EXPLANATORY MEMORANDUM

Notice is given that the Annual General Meeting of shareholders of Parnell Pharmaceuticals Holdings Ltd (Company) will be held on:

Friday, December 1st 2023 at 8:30 a.m. (Australian Eastern Standard Time)

The meeting is to be held in person at the Company's headquarters: First Floor, Unit 4, 476 Gardeners Road, Alexandria NSW, 2015, Australia

For a link to the full Notice of Annual General Meeting and Explanatory Memorandum please click:

https://cdn.newswire.com/files/x/34/3a/113c6dd4b6bfdd9c66c2792ca5da.pdf

_________________________________

23rd October 2023

Dear Shareholder,

On behalf of the Board of Directors of Parnell Pharmaceuticals Holdings Limited (ACN 137 904 413) (Company), I invite you to join us at our Annual General Meeting (AGM), which has been scheduled as follows:

Date: Friday, December 1st 2023 (AEST)
Time: 8:30 a.m. (AEST)
Venue: Held by physical attendance at: First Floor, Unit 4 Century Estate, 476 Gardeners Road, Alexandria, NSW, 2015

Outline of the items of business

At this AGM, we will provide an opportunity for shareholders to consider the following:

• the Company's financial statements and related documents for the year ended December 31, 2022;
• ratification of the appointment of the Company auditor; and
• re-election of Mr Doug Schillinger as a director of the Company.

Details of this business are contained in the enclosed Notice of GM and Explanatory Memorandum.

Voting at the GM or by proxy

A proxy form accompanies the enclosed Notice of AGM. If you wish to attend the AGM in person, please bring a copy of the proxy form with you. Registration will be available from 8:00 a.m. (AEST). If you are unable to attend in person, I encourage you to appoint a proxy to vote on the resolutions contained in the Notice of AGM on your behalf, by completing and returning the enclosed proxy form. Details of how to submit the proxy form are included with the form.

If you have any difficulties placing your vote via proxy please do not hesitate to contact Brad McCarthy at brad.mccarthy@parnell.com or call +612 9667 4411.

On behalf of all of the Directors, we look forward to hearing from you at the AGM.

Yours sincerely,

Alan Bell
Chairman

Related Files

Parnell 2023 Notice of Annual General Meeting and Ex Mem - Final (20.10.23).pdf
Financial Statements Parnell FY 2022 - Executed.pdf

SOURCE: Parnell Pharmaceuticals Holdings Ltd

View source version on accesswire.com:
https://www.accesswire.com/799475/parnell-pharmaceuticals-gives-notice-of-annual-general-meeting-and-explanatory-memorandum

FAQ

When is Parnell Pharmaceuticals Holdings Ltd's Annual General Meeting?

Parnell Pharmaceuticals Holdings Ltd's Annual General Meeting is scheduled for December 1st, 2023.

Where will the Annual General Meeting of Parnell Pharmaceuticals Holdings Ltd be held?

The Annual General Meeting of Parnell Pharmaceuticals Holdings Ltd will be held at the company's headquarters: First Floor, Unit 4, 476 Gardeners Road, Alexandria NSW, 2015, Australia.

What will be discussed at the Annual General Meeting of Parnell Pharmaceuticals Holdings Ltd?

The Annual General Meeting of Parnell Pharmaceuticals Holdings Ltd will cover the review of financial statements for the year ended December 31, 2022, ratification of the appointment of the company auditor, and the re-election of Mr. Doug Schillinger as a director.

How can shareholders vote at the Annual General Meeting of Parnell Pharmaceuticals Holdings Ltd?

Shareholders can vote at the Annual General Meeting of Parnell Pharmaceuticals Holdings Ltd by attending in person or appointing a proxy to vote on their behalf. Proxy forms are available and can be submitted as instructed.